PHUSIS THERAPEUTICS, INC.
PHT-427, a topical dual AKT/PDK1 inhibitor for treating actinic keratosis and squamous cell carcinoma
- Sector
- Biotech
- Total capital
- $2.1M
- Federal grants
- $2.1M
- 1 award · 2025
- Rank in peer group#7 of 326
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 5 pending · first 2016
- Rank in peer group#58 of 326
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Clinical evaluation of a novel AKT/PDK1 inhibitor, PHT-427, for the treatment of multi-field actinitc keratoses$2.1M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 326 peers
Line = medianBiotech · Molecule
- Federal grants#7 · top 2%
- Granted patents#58 · top 18%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 2 granted of 7- GrantedCompounds, Compositions And Methods For Inhibiting CNKSR1USPTOUS 10,227,356
- GrantedMethods And Compositions For Inhibiting CNKSR1USPTOUS 9,340,532
- PendingMethods And Compositions For Inhibiting CNKSR1USPTOApplication PCTUS2013075505
Show all 7 patent records
- Compounds, Compositions And Methods For Inhibiting CNKSR1Mar 12, 2019 · US 10,227,356Granted
- Methods And Compositions For Inhibiting CNKSR1May 17, 2016 · US 9,340,532Granted
- Methods And Compositions For Inhibiting CNKSR1Application PCTUS2013075505Pending
- Methods and Compositions for Inhibiting CNKSR1Application 61737658Pending
- Pharmaceutical Compositions And Formulations Including Inhibitors Of The Pleckstrin Homology Domain And Methods For Using SameApplication PCTUS2010048813Pending
- Compounds, Compositions And Methods For Inhibiting CNKSR1Application 62150219Pending
- Compounds, Compositions And Methods For Inhibiting CNKSR1Application PCTUS2016028414Pending
Related companies, and why
- EXONANORNA, LLCSimilar federal contract value in Biotech · null in contracts
- Gadusol Laboratories, Inc.Similar federal contract value in Biotech · null in contracts
- MARPAM PHARMA, LLCSimilar federal contract value in Biotech · null in contracts
- EINSENCA INC.Similar federal contract value in Biotech · null in contracts
- FURANICA, INC.Similar federal contract value in Biotech · null in contracts
- Biohaven PharmaceuticalSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .